Opko Issuance Of Capital Stock from 2010 to 2024

OPK Stock  USD 1.58  0.02  1.28%   
Opko Health Issuance Of Capital Stock yearly trend continues to be quite stable with very little volatility. The value of Issuance Of Capital Stock is projected to decrease to 855.00. From the period between 2010 and 2024, Opko Health, Issuance Of Capital Stock regression line of its data series had standard deviation of  44,528,398 and standard deviation of  44,528,398. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
900
Current Value
855
Quarterly Volatility
44.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 110.6 M, Interest Expense of 14.2 M or Total Revenue of 906.7 M, as well as many indicators such as Price To Sales Ratio of 1.25, Dividend Yield of 0.0011 or PTB Ratio of 0.78. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
  
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Latest Opko Health's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Opko Health over the last few years. It is Opko Health's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

Opko Issuance Of Capital Stock Regression Statistics

Arithmetic Mean60,571,050
Geometric Mean0.00
Coefficient Of Variation73.51
Mean Deviation40,380,200
Median92,500,000
Standard Deviation44,528,398
Sample Variance1982.8T
Range92.5M
R-Value(0.84)
Mean Square Error624.1T
R-Squared0.71
Significance0.000085
Slope(8,376,270)
Total Sum of Squares27758.9T

Opko Issuance Of Capital Stock History

2024 855.0
2023 900.0
2021 1000.0
2020null
201976.1 M

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as Issuance Of Capital Stock, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Issuance Of Capital Stock 900.00  855.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.191
Earnings Share
(0.19)
Revenue Per Share
0.998
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.09)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.